Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Shares Issued (2016 - 2025)

Amphastar Pharmaceuticals has reported Shares Issued over the past 12 years, most recently at $2.0 million for Q4 2025.

  • Quarterly results put Shares Issued at $2.0 million for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $8.0 million (changed N/A YoY), and the annual figure for FY2025 was $2.9 million, changed.
  • Shares Issued for Q4 2025 was $2.0 million at Amphastar Pharmaceuticals, up from $379000.0 in the prior quarter.
  • Over the last five years, Shares Issued for AMPH hit a ceiling of $5.7 million in Q4 2021 and a floor of $379000.0 in Q3 2025.
  • Median Shares Issued over the past 4 years was $2.1 million (2022), compared with a mean of $2.6 million.
  • Biggest five-year swings in Shares Issued: soared 205.5% in 2021 and later plummeted 64.0% in 2022.
  • Amphastar Pharmaceuticals' Shares Issued stood at $5.7 million in 2021, then plummeted by 64.0% to $2.0 million in 2022, then soared by 74.68% to $3.6 million in 2023, then crashed by 44.33% to $2.0 million in 2025.
  • The last three reported values for Shares Issued were $2.0 million (Q4 2025), $379000.0 (Q3 2025), and $3.6 million (Q4 2023) per Business Quant data.